Handelsbanken Fonder’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-28,744
Closed -$6.04M 178
2016
Q4
$6.04M Sell
28,744
-106,000
-79% -$22M 0.18% 107
2016
Q3
$31M Buy
134,744
+50,990
+61% +$12.5M 0.91% 42
2016
Q2
$19.4M Buy
+83,754
New +$19.3M 0.79% 53

Other funds holding AGN

Handelsbanken Fonder's AGN Position: Q1 2017 in Review

Handelsbanken Fonder sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 28,744 shares — an estimated $6.04M sold.

Handelsbanken Fonder first reported a position in AGN in Q2 2016 and held it in 3 quarters. The position peaked at $31M in Q3 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Handelsbanken Fonder reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Handelsbanken Fonder sold 28,744 Allergan plc shares in Q1 2017, an estimated $6.04M.
  • Handelsbanken Fonder first reported a position in Allergan plc in Q2 2016 and held it in 3 quarters.
  • Handelsbanken Fonder's Allergan plc position peaked at $31M in Q3 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Handelsbanken Fonder's 13F filing for Q1 2017, filed 4 May 2017.